Role of Protein Kinase A (PKA)-mediated mesenchymal-epithelial crosstalk in gastric preneoplasia
蛋白激酶 A (PKA) 介导的间充质-上皮串扰在胃肿瘤前期的作用
基本信息
- 批准号:10627168
- 负责人:
- 金额:$ 14.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-17 至 2027-04-30
- 项目状态:未结题
- 来源:
- 关键词:AdenocarcinomaAllelesAmerican Society of Clinical OncologyAnti-Inflammatory AgentsAntibiotic TherapyAtrophicAtrophic GastritisAutomobile DrivingBiomedical ResearchBone Morphogenetic ProteinsCancer EtiologyCancerousCause of DeathCellsCessation of lifeChronicCommunicationCyclic AMP-Dependent Protein KinasesDataDown-RegulationEpithelial-Stromal CommunicationEpitheliumGastric AdenocarcinomaGastric Parietal CellsGastritisGeneticGlandGrowthHelicobacterHelicobacter InfectionsHelicobacter felisHelicobacter pyloriHomeostasisHyperplasiaIncidenceInfectionInflammationInflammation MediatorsInflammatoryInflammatory InfiltrateInflammatory ResponseIntestinal Intraepithelial NeoplasiaLesionLigandsMediatingMesenchymalMesenchymeMessenger RNAMetaplasiaModelingMolecularMucous MembraneMucous body substanceMusMutant Strains MiceNeoplasmsOutcomePathologicPathologyPathway interactionsPatientsPhosphorylationPredispositionPreneoplastic ConditionsPrevention strategyProliferatingProteinsResearchRiskRisk FactorsRoleSTAT3 geneSeriesSeveritiesSignal TransductionSignaling ProteinStimulusStomachStromal CellsStudentsTestingTissuesTrainingTransgenic MiceTransgenic OrganismsUniversitiesUp-Regulationantagonistconditional mutantconstitutive expressioncytokineeffective therapyexperimental studygastric carcinogenesisgastric intestinal metaplasiagastric pre-neoplasiahigh riskinflammatory milieuinhibitormalignant stomach neoplasmminority studentneoplasticnoveloverexpressionpremalignantpreventpromoterspasmolytic polypeptidesynergismtreatment strategytumor
项目摘要
Project Summary
According to the American Society of Clinical Oncology, in the year 2020, stomach cancer caused death of
768,793 patients worldwide making it the fourth leading cause of cancer deaths. H. pylori infection is the
strongest risk factor for gastric cancer. H. pylori-initiated inflammation leads to atrophic gastritis, spasmolytic
polypeptide expressing metaplasia (SPEM), gastric intestinal metaplasia (GIM) and dysplasia, a series of
preneoplastic lesions strongly associated with gastric cancer. The eradication of H. pylori by antibiotic treatment
has been effective in reducing the incidence of preneoplastic lesions and gastric cancer. However, following H.
pylori eradication already established mucosal metaplastic changes may not reverse, and the risk of gastric
cancer in such patients remains high. A better understanding of the mechanisms contributing to inflammation
and the resulting preneoplastic lesions is required to develop rational and effective therapies. One of the
mechanisms by which H. pylori stimulates inflammatory signaling and preneoplastic lesions is by disrupting the
communication between the gastric epithelium and the surrounding mesenchyme/stroma. We have identified a
novel role of PKA activation in the gastric mesenchyme in establishing a proinflammatory and preneoplastic state
that is associated with downregulation of BMP signaling which is known to be a key regulator of gastric
inflammation and preneoplasia. We generated and characterized a novel conditional mutant mouse Six2Cre+/--
PKAcRfl/wt (CA-PKA) model in which single allele-mediated expression of constitutively active PKA (PKAcR)
was induced in the stomach mesenchyme using Six2-Cre transgenic mice. CA-PKA Mice develop preneoplastic
lesions such as atrophic gastritis, SPEM, GIM and dysplasia along with marked chronic inflammation, factors
strongly associated with gastric cancer The central hypothesis of this proposal is that PKA activation in the gastric
mesenchyme is a key driver of gastric carcinogenesis by inciting inflammation and inhibiting BMP signaling that
will be tested in the following three aims. Aim 1 is to determine the mechanisms that contribute to inflammation
and oxyntic atrophy in CA-PKA mice. Aim 2 is to determine the effects of genetic modulation of BMP pathway
inhibitor gremlin 1 (Grem1) on the severity of gastric preneoplastic lesions in CA-PKA mice. Aim 3 is to determine
the impact of misregulated PKA signaling on H. felis-induced gastric pathology. Expected outcomes of the
proposed research will define the molecular and functional significance of mis-regulated PKA signaling in
disrupting gastric homeostasis and driving pathology. A better understanding of misregulated PKA signaling as
an underlying cause of gastric inflammation and preneoplasia can help develop preventative and treatment
strategies for gastric cancer and associated pathological conditions.
项目摘要
根据美国临床肿瘤学会的数据,在2020年,胃癌导致
全球有768,793名患者,使其成为癌症死亡的第四大原因。H.幽门螺杆菌感染是
胃癌的最大危险因素。H.幽门启动的炎症导致萎缩性胃炎、痉挛性胃炎、
多肽表达性化生(SPEM)、胃肠化生(GIM)和异型增生,一系列
与胃癌密切相关的癌前病变。H.抗生素治疗幽门螺杆菌
有效降低癌前病变和胃癌的发病率。然而,继H.
幽门螺杆菌根除已经建立的粘膜化生改变可能不会逆转,
这类患者的癌症发病率仍然很高。更好地了解炎症的机制
并且需要由此产生的癌前病变来开发合理和有效的治疗。之一
H.幽门螺杆菌刺激炎症信号和癌前病变是通过破坏
胃上皮和周围间充质/基质之间的沟通。我们已经确定了一
胃间质PKA激活在建立促炎和癌前状态中的新作用
这与BMP信号转导的下调有关,BMP信号转导已知是胃肠道的关键调节因子,
炎症和瘤前病变。我们产生并表征了一种新的条件突变小鼠Six 2Cre +/--
PKAc β Rfl/wt(CA-PKA)模型,其中单个等位基因介导的组成型活性PKA(PKAc β R)的表达
使用Six 2-Cre转基因小鼠在胃间充质中诱导。CA-PKA小鼠发生癌前病变
病变,如萎缩性胃炎,SPEM,GIM和异型增生,沿着明显的慢性炎症,因子
该建议的中心假设是,PKA在胃中的激活与胃癌密切相关。
间充质是通过刺激炎症和抑制BMP信号传导的胃癌发生的关键驱动因素,
将在以下三个目标中进行测试。目的1是确定导致炎症的机制
和CA-PKA小鼠的泌酸性萎缩。目的二是确定BMP通路的基因调控作用
抑制剂gremlin 1(Grem 1)对CA-PKA小鼠胃肿瘤前病变严重程度的影响。目标3:确定
PKA信号的错误调节对H.猫引起的胃病理学预期成果
拟议的研究将确定错误调节PKA信号传导的分子和功能意义,
破坏胃内环境稳定和驱动病理学。更好地理解PKA信号的错误调节,
胃炎症和癌前病变的根本原因可以帮助制定预防和治疗
胃癌和相关病理条件的策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Pawan Puri其他文献
Pawan Puri的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Pawan Puri', 18)}}的其他基金
Protein Kinase A (PKA) Signaling in the Cystogenesis and Dedifferentiation of Proximal Tubules
近端小管囊肿发生和去分化中的蛋白激酶 A (PKA) 信号转导
- 批准号:
10000947 - 财政年份:2018
- 资助金额:
$ 14.7万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 14.7万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 14.7万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 14.7万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 14.7万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 14.7万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 14.7万 - 项目类别:
Studentship
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 14.7万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 14.7万 - 项目类别:
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 14.7万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 14.7万 - 项目类别: